Landscape → Immunology

Ankylosing Spondylitis Clinical Trial Landscape

Data updated: May 20, 2026

135 clinical trials tracked since 2008

Ankylosing Spondylitis is being studied across 135 clinical trials registered since 2008, with 21 programs currently active. The competitive pipeline includes 8 active Phase 3 trials, 8 active Phase 2 trials, and 3 active Phase 1 trials. Top industry sponsors include UCB Biopharma SRL, Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Jiangsu vcare pharmaceutical technology co., LTD.

21 active

135 total (since 2008)

Phase 1 Active

30 total

Phase 2 Active

44 total

Phase 3 Active

45 total

Phase 4 Active

24 total

Top Industry Sponsors

Sorted by active Active Done Failed

UCB Biopharma SRL 1 3 0

Suzhou Zelgen Biopharmaceuticals Co.,Ltd 1 1 0

Jiangsu vcare pharmaceutical technology co., LTD 1 1 0

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 1 1 0

Lynk Pharmaceuticals Co., Ltd 1 1 0

+ 9 more sponsors — see full table below

Featured Phase 3 Trials

NCT04436640 ACTIVE NOT RECRUITING

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

UCB Biopharma SRL n=508

NCT05861102 ACTIVE NOT RECRUITING

Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)

Suzhou Zelgen Biopharmaceuticals Co.,Ltd n=265

NCT07172360 RECRUITING

Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Jiangsu vcare pharmaceutical technology co., LTD n=420

NCT07261644 RECRUITING

A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. n=500

NCT07237568 RECRUITING

A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis

Lynk Pharmaceuticals Co., Ltd n=352

+ 40 more Phase 3 trials — see full database below

Ankylosing Spondylitis — Trials Started by Year (last 10 years)

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

TheraRadar.com

Full Trial Database

Complete sponsor table, every trial across all phases, plus competitive analytics. Sortable, filterable, exportable for Pro users.

Top Sponsors (all-time)

UCB Biopharma SRL

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Jiangsu vcare pharmaceutical technology co., LTD

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Lynk Pharmaceuticals Co., Ltd

Shenzhen Huishan Biotechnology Co., Ltd.

XBiotech, Inc.

Tasly Pharmaceutical Group Co., Ltd

Asia Cell Therapeutics (Shanghai) Co., Ltd.

Bayer

Active Trials by Phase

Phase 1

Phase 2

Phase 3

Phase 4

Enrollment Size Distribution

1-50

51-200

201-500

501-1k

1k+

All Industry Sponsors

Sorted by active Active Done Failed

UCB Biopharma SRL 1 3 0

Suzhou Zelgen Biopharmaceuticals Co.,Ltd 1 1 0

Jiangsu vcare pharmaceutical technology co., LTD 1 1 0

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 1 1 0

Lynk Pharmaceuticals Co., Ltd 1 1 0

Shenzhen Huishan Biotechnology Co., Ltd. 1 0 0

XBiotech, Inc. 1 0 0

Tasly Pharmaceutical Group Co., Ltd 1 0 0

Asia Cell Therapeutics (Shanghai) Co., Ltd. 1 0 0

Bayer 0 15 0

Novartis 0 8 0

Biocad 0 4 0

Pfizer 0 2 2

Merck 0 2 1

NCT04436640 ACTIVE NOT RECRUITING

UCB Biopharma SRL n=508

NCT07512960 NOT YET RECRUITING

Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization

Fondation Hôpital Saint-Joseph n=614

NCT05861102 ACTIVE NOT RECRUITING

Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)

Suzhou Zelgen Biopharmaceuticals Co.,Ltd n=265

NCT07172360 RECRUITING

Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Jiangsu vcare pharmaceutical technology co., LTD n=420

NCT07261644 RECRUITING

A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. n=500

NCT07237568 RECRUITING

A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis

Lynk Pharmaceuticals Co., Ltd n=352

NCT06000956 RECRUITING

A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo

Tasly Pharmaceutical Group Co., Ltd n=408

NCT06452498 NOT YET RECRUITING

Preeclampsia Intervention Netherlands

Amsterdam UMC n=180

NCT06378697 COMPLETED

A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis

Akeso n=510

NCT03928743 COMPLETED

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis

UCB Biopharma SRL n=332

NCT07277179 COMPLETED

Evaluate the Efficacy, Safety, and Pharmacokinetic Profile and Immunogenicity of Subcutaneous Netakimab in Chinese Adult Patients With Active Ankylosing Spondylitis

SPH-BIOCAD (HK) Limited n=113

NCT02186873 COMPLETED

A Study of Golimumab in Participants With Active Ankylosing Spondylitis

Janssen Research & Development, LLC n=208

NCT03447704 COMPLETED

International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis

Biocad n=228

NCT06985134 COMPLETED

Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh n=93

NCT02469753 COMPLETED

Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes

University Hospital, Bordeaux n=188

NCT04156620 COMPLETED

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

Novartis Pharmaceuticals n=527

NCT04840485 COMPLETED

Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis

Suzhou Suncadia Biopharmaceuticals Co., Ltd. n=548

NCT04106557 COMPLETED

A Study of OV101 in Individuals With Angelman Syndrome (AS)

Healx AI n=104

NCT03746522 COMPLETED

Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity

Rhythm Pharmaceuticals, Inc. n=52

NCT03259074 COMPLETED

Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)

Novartis Pharmaceuticals n=859

NCT04481139 COMPLETED

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis

Jiangsu HengRui Medicine Co., Ltd. n=504

NCT03502616 COMPLETED

Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)

Pfizer n=270

NCT00762463 COMPLETED

Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. n=240

NCT04483700 WITHDRAWN

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy

Gilead Sciences

NCT04483687 WITHDRAWN

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy

Gilead Sciences

NCT02505542 COMPLETED

Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo

UCB BIOSCIENCES GmbH n=736

NCT04345458 COMPLETED

Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. n=640

NCT04174131 COMPLETED

Restylane + Lidocaine and Restylane Lyft for the Treatment of Nasolabial Folds

Erevna Innovations Inc. n=10

NCT03357471 COMPLETED

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

UCB Biopharma S.P.R.L. n=70

NCT04135508 COMPLETED

A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira

Bio-Thera Solutions n=554

NCT02750592 COMPLETED

Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis

Novartis Pharmaceuticals n=30

NCT02685904 TERMINATED

A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

Mycenax Biotech Inc. n=10

NCT02893254 COMPLETED

Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis

Innovent Biologics (Suzhou) Co. Ltd. n=438

NCT02762812 COMPLETED

Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis

Biocad n=199

NCT02163330 TERMINATED

Normal Pressure Hydrocephalus Treatment by Acetazolamide

Rabin Medical Center n=2

NCT00844805 COMPLETED

Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)

Merck Sharp & Dohme LLC n=158

NCT01358175 COMPLETED

16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis

Novartis Pharmaceuticals n=371

NCT01694264 TERMINATED

Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα

Seoul National University Hospital n=43

NCT01586650 COMPLETED

Effects of Aerobic Training in Patients With Ankylosing Spondylitis

Federal University of São Paulo n=70

NCT01091675 COMPLETED

Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs

Spanish Foundation of Rheumatology n=58

NCT01671852 WITHDRAWN

Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy

Children's & Women's Health Centre of British Columbia

NCT01248793 COMPLETED

Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis

Centocor, Inc. n=213

NCT01639027 COMPLETED

Drotaverine to Shorten the Length of Labor

Ain Shams Maternity Hospital n=352

NCT00667355 COMPLETED

A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis

Abbott n=41

NCT01114880 COMPLETED

Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis

Abbott n=344

NCT07534644 NOT YET RECRUITING

A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis

Shenzhen Huishan Biotechnology Co., Ltd.

NCT07534033 RECRUITING

Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer

Zhujiang Hospital

NCT06957691 RECRUITING

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Shehzad Basaria, M.D.

NCT06526377 NOT YET RECRUITING

Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy

XBiotech, Inc.

NCT04924270 RECRUITING

Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases

Odense University Hospital

NCT06888973 ENROLLING BY INVITATION

Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases

National Institute of Blood and Marrow Transplant (NIBMT), Pakistan

NCT06451588 RECRUITING

Fecal Microbiota Transplantation in Axial Spondyloarthritis

University Hospital of North Norway

NCT01898416 RECRUITING

Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors

michal roll

NCT03355573 COMPLETED

A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis

UCB Biopharma SRL

NCT05814939 COMPLETED

Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Jiangsu vcare pharmaceutical technology co., LTD

NCT03926195 COMPLETED

Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis

Galapagos NV

NCT05467995 COMPLETED

A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis

Akeso

NCT05407246 COMPLETED

Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis

Tianjin Hemay Pharmaceutical Co., Ltd

NCT06085534 COMPLETED

A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis

Lynk Pharmaceuticals Co., Ltd

NCT03215277 COMPLETED

A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis

UCB Biopharma SRL

NCT04795141 TERMINATED

ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis

Inmagene LLC

NCT02963506 COMPLETED

A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis

UCB Biopharma S.P.R.L.

NCT04507659 COMPLETED

Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

NCT03178487 COMPLETED

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

AbbVie

NCT04229940 COMPLETED

Peritoneal in Laparoscopic Ventral Hernia Repair 2

Karolinska Institutet

NCT02538341 COMPLETED

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

NCT02980705 TERMINATED

Efficacy and Safety Study of SUNPG1622

Sun Pharmaceutical Industries Limited

NCT02763111 COMPLETED

Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis

Biocad

NCT01988506 COMPLETED

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Assistance Publique - Hôpitaux de Paris

NCT01109940 COMPLETED

Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis

Novartis Pharmaceuticals

NCT00811499 TERMINATED

A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis

Pfizer

NCT02328027 TERMINATED

99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)

Advanced Accelerator Applications

NCT00944658 COMPLETED

Spondylitis Trial of Apremilast for Better Rheumatic Therapy

Imperial College London

NCT03329885 TERMINATED

A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis

Bristol-Myers Squibb

NCT02047110 COMPLETED

BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)

AbbVie

NCT03140657 COMPLETED

The Effects of Nanocurcumin on Treg Cells and Th17 Cells Responses in Ankylosing Spondylitis Patients

Tabriz University of Medical Sciences

NCT03117270 COMPLETED

A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis

Galapagos NV

NCT01061723 COMPLETED

Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis

Sanofi

NCT01118728 TERMINATED

Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis

Sanofi

NCT01786668 COMPLETED

Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis

Pfizer

NCT00809159 COMPLETED

Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis

Novartis Pharmaceuticals

NCT02201043 COMPLETED

Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis

Shanghai Pharmaceuticals Holding Co., Ltd

NCT02238912 COMPLETED

Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai

National institute of Siddha

NCT01732055 TERMINATED

Partner-Assisted Interpersonal Psychotherapy or Antidepressant Medication for Antenatal Depression

University of North Carolina, Chapel Hill

NCT01330901 COMPLETED

Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis

Charite University, Berlin, Germany

NCT01463189 COMPLETED

Web-based Support to Manage Arthritis Pain

Inflexxion, Inc.

NCT05962762 NOT YET RECRUITING

Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Ankylosing Spondylitis

Asia Cell Therapeutics (Shanghai) Co., Ltd.

NCT05071729 COMPLETED

A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally

Bayer

NCT06219902 COMPLETED

A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Bayer

NCT04845841 COMPLETED

Comparison of the Extent to Which the Drug Given as Two Different Capsule Sizes Becomes Available to the Body

Bayer

NCT04889287 COMPLETED

A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants

Bayer

NCT05585398 COMPLETED

A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods

Merz Pharmaceuticals GmbH

NCT05481528 COMPLETED

A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

Bayer

NCT05471817 COMPLETED

A Study to Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female Participants

Bayer

NCT05381142 COMPLETED

A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 Years

Bayer

NCT05351892 COMPLETED

A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants

Bayer

NCT04981431 COMPLETED

A Study to Learn How Safe Elinzanetant is, How it Affects the Body, and How it Moves Into, Through and Out of the Body After Single and Multiple Doses in Japanese Healthy Female Adults

Bayer

NCT04903821 COMPLETED

A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

Bayer

NCT05061563 COMPLETED

A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

Bayer

NCT05028608 COMPLETED

A Study to Learn What Happens to Elinzanetant in the Body When Taken With or Without Carbamazepine, and How Safe it is in Healthy Men and Women Aged 18 to 60 Years.

Bayer

NCT04018599 COMPLETED

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Fresenius Kabi SwissBioSim GmbH

NCT02019602 COMPLETED

A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta

UCB BIOSCIENCES, Inc.

NCT03212586 COMPLETED

BAY 1902607: Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Bioavailability, Food Effect

Bayer

NCT02154425 COMPLETED

A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers

UCB BIOSCIENCES, Inc.

NCT02817100 COMPLETED

First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080

Bayer

NCT02144051 COMPLETED

Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

AstraZeneca

NCT02359903 COMPLETED

Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis

Biocad

NCT01514955 WITHDRAWN

An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer

AHS Cancer Control Alberta

NCT02212080 COMPLETED

First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784

Bayer

NCT01571206 COMPLETED

An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1

Celltrion

NCT01220518 COMPLETED

Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)

Celltrion

NCT07582146 NOT YET RECRUITING

Effectiveness and Safety of Acemetacin in Active Axial Spondyloarthritis: A Real-world Study

Chinese PLA General Hospital

NCT05303285 RECRUITING

A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis

Tongji Hospital

NCT06707194 RECRUITING

Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis

Nanfang Hospital, Southern Medical University

NCT06833112 NOT YET RECRUITING

Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis

The Affiliated Hospital Of Guizhou Medical University

NCT01895764 COMPLETED

Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)

University Hospital, Tours

NCT07075783 COMPLETED

The Efficacy and Safety of Magnesium Sulphate Adjuvant in Scalp Block With Ropivacaine for Supratentorial Craniotomy: a Prospective, Randomized Controlled Trial

Hospital Universiti Sains Malaysia

NCT03350815 COMPLETED

Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis

Novartis Pharmaceuticals

NCT03988231 WITHDRAWN

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

University of Utah

NCT02763046 COMPLETED

Study to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis

Novartis Pharmaceuticals

NCT02758782 COMPLETED

NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis

Charite University, Berlin, Germany

NCT02492217 COMPLETED

Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients

Universidade Nova de Lisboa

NCT03473665 TERMINATED

Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis

Columbia University

NCT03411798 COMPLETED

Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS

Nanfang Hospital, Southern Medical University

NCT01668004 COMPLETED

The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)

Merck Sharp & Dohme LLC

NCT03800797 COMPLETED

Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis

Sun Yat-sen University

NCT03681574 COMPLETED

Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology

Hospital Infantil Albert Sabin

NCT01934933 COMPLETED

Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis

Sun Yat-sen University

NCT00910273 TERMINATED

Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients

Pfizer

NCT01148901 WITHDRAWN

Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451)

Merck Sharp & Dohme LLC

NCT01212653 COMPLETED

Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)

Chinese University of Hong Kong

NCT00715091 COMPLETED

Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis

Charite University, Berlin, Germany

NCT01517620 COMPLETED

Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF Therapy

Sun Yat-sen University

NCT00953979 COMPLETED

Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis

Gu Jieruo

NCT00647517 COMPLETED

Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis

Chung Shan Medical University

Full Ankylosing Spondylitis Pipeline

Every sponsor, every trial across Phase 1–4. Sortable, filterable, exportable.

Unlock with Pro

Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only